| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99232 |
Subsequent hospital care, per day, moderate complexity |
11,893 |
4,044 |
$416K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,212 |
4,918 |
$389K |
| 99233 |
Prolong inpt eval add15 m |
7,536 |
2,463 |
$368K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
16,063 |
4,192 |
$333K |
| 99223 |
Prolong inpt eval add15 m |
1,826 |
1,587 |
$215K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,093 |
2,562 |
$145K |
| 99222 |
Initial hospital care, per day, moderate complexity |
773 |
711 |
$93K |
| 99215 |
Prolong outpt/office vis |
901 |
781 |
$79K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
1,078 |
941 |
$57K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
864 |
774 |
$56K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
1,292 |
588 |
$29K |
| 99221 |
|
264 |
234 |
$29K |
| 99220 |
|
100 |
89 |
$21K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
142 |
71 |
$18K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
144 |
128 |
$14K |
| 36415 |
Collection of venous blood by venipuncture |
910 |
781 |
$10K |
| 99000 |
|
221 |
169 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
140 |
119 |
$6K |
| 99497 |
|
198 |
152 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
59 |
49 |
$5K |
| 80305 |
|
593 |
488 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
474 |
328 |
$4K |
| Q3014 |
Telehealth originating site facility fee |
171 |
151 |
$4K |
| 96127 |
|
1,563 |
994 |
$4K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
58 |
43 |
$4K |
| 99236 |
Prolong inpt eval add15 m |
18 |
14 |
$4K |
| 99217 |
|
76 |
73 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
217 |
94 |
$3K |
| 99305 |
|
50 |
47 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
29 |
27 |
$2K |
| 1123F |
|
122 |
100 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
190 |
143 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
40 |
38 |
$1K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
29 |
26 |
$921.49 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
59 |
54 |
$768.03 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
20 |
17 |
$551.62 |
| 99406 |
|
60 |
53 |
$507.12 |
| 90674 |
|
13 |
13 |
$410.04 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
29 |
27 |
$401.76 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
92 |
77 |
$345.45 |
| 99401 |
|
17 |
16 |
$312.60 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
14 |
14 |
$122.36 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
16 |
14 |
$120.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
28 |
25 |
$59.44 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
55 |
36 |
$55.29 |
| 81003 |
|
27 |
25 |
$30.55 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
13 |
12 |
$16.95 |
| G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) |
17 |
12 |
$2.72 |
| 3079F |
|
14 |
12 |
$0.00 |
| 3008F |
|
16 |
16 |
$0.00 |
| 99442 |
|
36 |
27 |
$0.00 |
| 99490 |
Ccm add 20min |
14 |
14 |
$0.00 |
| G2068 |
Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) |
13 |
12 |
$0.00 |
| 3077F |
|
14 |
12 |
$0.00 |